Device Trial Radar · NCT00791128
Study for Pre-Surgical Weight Loss in Type II Diabetes Patients
Last checked: Nov 20, 2026Latest source record: Jun 1, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
22
Actual
Start
Oct 2008
Primary completion
Mar 2010
Study completion Dec 2010
Sponsor
- Lead sponsor
- Morphic Medical Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 14, 2008
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether the GI Sleeve is safe and effective in treating Type II diabetes patients
Conditions
- Type 2 Diabetes
- Obesity
Interventions
GI LinerDevice
Medical device placed endoscopically in the duodenum, nutritional counseling
Primary outcomes
What the sponsor says the trial is designed to measure.
- % of Excess Weight Loss (EWL)Time frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Dr. Eduardo Guimaraes Hourneauz de Moura
São Paulo, São Paulo, Brazil
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.